The Food and Drug Administration has granted Alembic tentative approval for Bosutinib Tablets, 100 mg and 500 mg, which is the generic of PF Prism’s Bosulif Tablets. Bosutinib Tablets are indicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback